Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
Authors:
Open Access
- 27 November 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11
Abstract
Epithelial-mesenchymal Transition (EMT) is a de-differentiation process in which epithelial cells lose their epithelial properties to acquire mesenchymal features. EMT is essential for embryogenesis and wound healing but is aberrantly activated in pathological conditions like fibrosis and cancer. Tumor-associated EMT contributes to cancer cell initiation, invasion, metastasis, drug resistance and recurrence. This dynamic and reversible event is governed by EMT-transcription factors (EMT-TFs) with epigenetic complexes. In this review, we discuss recent advances regarding the mechanisms that modulate EMT in the context of epigenetic regulation, with emphasis on epigenetic drugs, such as DNA demethylating reagents, inhibitors of histone modifiers and non-coding RNA medication. Therapeutic contributions that improve epigenetic regulation of EMT will translate the clinical manifestation as treating cancer progression more efficiently.Keywords
Funding Information
- National Cancer Institute
- American Cancer Society
- National Institutes of Health
This publication has 136 references indexed in Scilit:
- Chromatin-modifying enzymes as modulators of reprogrammingNature, 2012
- A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cellsNature Chemical Biology, 2011
- The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasisCell Research, 2010
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule InhibitorChemistry & Biology, 2010
- The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine‐specific demethylase 1The EMBO Journal, 2010
- LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast CancerCell, 2009
- Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cellsNature Genetics, 2009
- Repression of E-cadherin by the polycomb group protein EZH2 in cancerOncogene, 2008
- LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcriptionNature, 2005
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004